ATP-sensitive inward rectifier potassium channel (KATP channel) (KATP channel)

The ATP-sensitive inward rectifier potassium (KATP) channel in pancreatic beta cells is a hetero-octameric complex composed of four Kir6.2 pore-forming subunits and four regulatory sulfonylurea receptor 1 (SUR1) subunits (UniProt P48048, Q09428). It serves as a critical metabolic sensor that couples the cell's metabolic state, specifically the ATP/ADP ratio, to its membrane potential to regulate insulin secretion (StatPearls, NBK525981). When blood glucose levels rise, increased intracellular ATP leads to the closure of these channels, causing membrane depolarization, the opening of voltage-gated calcium channels, and the subsequent exocytosis of insulin (PubMed, PMC2652495). Mutations in the genes encoding these subunits, KCNJ11 and ABCC8, are primary causes of neonatal diabetes and congenital hyperinsulinism (NIH, MedlinePlus). Pharmacologically, the KATP channel is the primary target for sulfonylureas and meglitinides, which are used to treat type 2 diabetes by stimulating insulin release (PubChem, CID 3488). Conversely, channel openers like diazoxide are utilized to manage conditions of insulin over-secretion by keeping the channels open and preventing depolarization (PubMed, PMC3136028).

Other names

ATP-sensitive potassium channelKir6.2/SUR1 complexK-ATP channelPancreatic beta-cell KATP channel

Sulfonylureas and meglitinides act as inhibitors that bind to the SUR1 subunit, promoting the closed state of the channel to trigger insulin release (PubMed, PMC2652495). Potassium channel openers like diazoxide stabilize the open conformation, hyperpolarizing the beta cell and inhibiting insulin release (PubMed, PMC3136028).